BACKGROUND: Chronic total coronary occlusions (CTOs) represent a subgroup of coronary lesions with a low procedural success and high recurrence rate. However, there is evidence for a prognostic benefit of revascularizing a CTO. OBJECTIVE: This study assessed the prevalence of CTOs among patients with stable angina pectoris and its impact on therapeutic strategies. METHODS: Between 2001 and 2003, a survey was conducted in 64 sites to analyze the outcome of the first diagnostic angiography in patients presenting with stable angina pectoris (STAR registry). The clinical characteristics, initial angiographic findings, therapeutic strategy and outcome within the first year were analyzed. RESULTS: A total of 2,002 patients were entered into the registry. One-third had at least one CTO. At 1 year, the mortality in patients with a CTO was significantly higher than in those without a CTO (5.5 vs. 3.1%; P = 0.009). This excess mortality was related to a higher prevalence of confounding factors in patients with a CTO such as diabetes and more severe LV dysfunction. Patients with a CTO were more likely to undergo surgery or being treated medically, whereas patients without a CTO were more likely to undergo PCI. If a CTO was treated by PCI the periprocedural and long-term outcome was similar to those with PCI for a non-occlusive lesion. However, periprocedural MACE was higher for patients treated for a non-occlusive lesion without first treating the CTO. CONCLUSIONS: The prevalence of CTOs in patients with stable angina pectoris is high, and it influences the clinical outcome within the first year. The therapeutic strategy is influenced towards a rather conservative approach and lower rates of interventional therapy.
BACKGROUND:Chronic total coronary occlusions (CTOs) represent a subgroup of coronary lesions with a low procedural success and high recurrence rate. However, there is evidence for a prognostic benefit of revascularizing a CTO. OBJECTIVE: This study assessed the prevalence of CTOs among patients with stable angina pectoris and its impact on therapeutic strategies. METHODS: Between 2001 and 2003, a survey was conducted in 64 sites to analyze the outcome of the first diagnostic angiography in patients presenting with stable angina pectoris (STAR registry). The clinical characteristics, initial angiographic findings, therapeutic strategy and outcome within the first year were analyzed. RESULTS: A total of 2,002 patients were entered into the registry. One-third had at least one CTO. At 1 year, the mortality in patients with a CTO was significantly higher than in those without a CTO (5.5 vs. 3.1%; P = 0.009). This excess mortality was related to a higher prevalence of confounding factors in patients with a CTO such as diabetes and more severe LV dysfunction. Patients with a CTO were more likely to undergo surgery or being treated medically, whereas patients without a CTO were more likely to undergo PCI. If a CTO was treated by PCI the periprocedural and long-term outcome was similar to those with PCI for a non-occlusive lesion. However, periprocedural MACE was higher for patients treated for a non-occlusive lesion without first treating the CTO. CONCLUSIONS: The prevalence of CTOs in patients with stable angina pectoris is high, and it influences the clinical outcome within the first year. The therapeutic strategy is influenced towards a rather conservative approach and lower rates of interventional therapy.
Authors: Carlo Di Mario; Gerald S Werner; Georgios Sianos; Alfredo R Galassi; Joachim Büttner; Dariusz Dudek; Bernard Chevalier; Thierry Lefevre; Joachim Schofer; Jacques Koolen; Horst Sievert; Bernhard Reimers; Jean Fajadet; Antonio Colombo; Anthony Gershlick; Patrick W Serruys; Nicolaus Reifart Journal: EuroIntervention Date: 2007-05 Impact factor: 6.534
Authors: V Dzavik; R G Carere; G B Mancini; E A Cohen; D Catellier; T E Anderson; G Barbeau; C Lazzam; L M Title; P B Berger; M Labinaz; K K Teo; C E Buller Journal: Am Heart J Date: 2001-08 Impact factor: 4.749
Authors: J Dawn Abbott; Kevin E Kip; Helen A Vlachos; Neil Sawhney; Vankeepuran S Srinivas; Alice K Jacobs; David R Holmes; David O Williams Journal: Am J Cardiol Date: 2006-04-21 Impact factor: 2.778
Authors: Gerald S Werner; Andreas Krack; Gero Schwarz; Dirk Prochnau; Stefan Betge; Hans R Figulla Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: Gerald S Werner; Philipp Bahrmann; Oliver Mutschke; Ulf Emig; Stefan Betge; Markus Ferrari; Hans R Figulla Journal: J Am Coll Cardiol Date: 2003-07-16 Impact factor: 24.094
Authors: Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns Journal: Eur Heart J Date: 2005-03-15 Impact factor: 29.983
Authors: Mandana Veiseh; Daniel Breadner; Jenny Ma; Natalia Akentieva; Rashmin C Savani; Rene Harrison; David Mikilus; Lisa Collis; Stefan Gustafson; Ting-Yim Lee; James Koropatnick; Leonard G Luyt; Mina J Bissell; Eva A Turley Journal: Biomacromolecules Date: 2011-12-12 Impact factor: 6.988
Authors: Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi Journal: Curr Atheroscler Rep Date: 2017-04 Impact factor: 5.113
Authors: Loes P Hoebers; Bimmer E Claessen; George D Dangas; Truls Råmunddal; Roxana Mehran; José P S Henriques Journal: Nat Rev Cardiol Date: 2014-05-27 Impact factor: 32.419